{"version":"1.0","type":"link","title":"Efficacy of Locoregional Treatment for Oligo-Drug-Resistant Lesions during First-Line Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma: A Single-Center Retrospective Study.","author_name":"Nakabori T 외","author_url":"https://prs-insight.online/author/Nakabori%20T","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/112759","thumbnail_width":1200,"thumbnail_height":630}